• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.11% Nasdaq Up 0.09%

    Biogen Inc. (BIIB)

    -NasdaqGS
    297.19 Up 1.41(0.48%) Dec 2, 4:00PM EST
    |Pre-Market : 297.19 0.00 (0.00%) 5:57PM EST - Nasdaq Real Time Price
    Prev Close:295.78
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:339.98
    Beta:0.327313
    Earnings Date:Jan 25 - Jan 30 (Est.)
    Day's Range:N/A - N/A
    52wk Range:223.02 - 333.65
    Volume:0
    Avg Vol (3m):1,540,120
    Market Cap:64.66B
    P/E (ttm):16.81
    EPS (ttm):17.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.48%64.66B
    PFEUp 0.54%191.94B
    ABTUp 0.80%55.80B

    Key Statistics

    Forward P/E (1 yr):14.26
    P/S (ttm):5.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :20.20
    Quarterly EPS Est (Dec-16) :4.99
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.65

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback